DLX6-AS1 and triple-negative breast carcinoma: In triple-negative breast cancer, the lncRNA DLX6 antisense RNA 1 was upregulated in cancer tissues, and its expression promoted cell proliferation, EMT, and cisplatin resistance by regulating the miR-199b-5p/PXN axis [52].